Showing results (101-110 of 392) with videos related to
Sort By:
Pageof 40
International Journal of Cancer|May 16, 2014
Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6Nupur Bhattacharya, Michaela Reichenzeller, Maiwen Caudron-Herger, et al.Frontiers in Oncology|March 8, 2021
Adjuvant Therapy of High-Risk (Stages IIC-IV) Malignant Melanoma in the Post Interferon-Alpha Era: A Systematic Review and Meta-AnalysisKonstantinos Christofyllakis, Claudia Pföhler, Moritz Bewarder, et al.British Journal of Haematology|May 28, 2011
Nurse-like cells show deregulated expression of genes involved in immunocompetenceNupur Bhattacharya, Susanne Diener, Irina S Idler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genesDirk L Kienle, Christian Korz, Beate Hosch, et al.British Journal of Haematology|January 16, 2007
Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapseMark Ringhoffer, Stephanie von Harsdorf, Michael Schmitt, et al.Future Oncology (London, England)|July 11, 2015
The CLL12 trial protocol: a placebo-controlled double-blind Phase III study of ibrutinib in the treatment of early-stage chronic lymphocytic leukemia patients with risk of early disease progressionPetra Langerbeins, Jasmin Bahlo, Christina Rhein, et al.International Journal of Cancer|May 9, 2022
Modeling the B-cell receptor signaling on single cell level reveals a stable network circuit topology between nonmalignant B cells and chronic lymphocytic leukemia cells and between untreated cells and cells treated with kinase inhibitorsChristine Wolf, Carsten Maus, Michael R O Persicke, et al.Blood|August 21, 2008
MYC stimulates EZH2 expression by repression of its negative regulator miR-26aSandrine Sander, Lars Bullinger, Kay Klapproth, et al.Cancer Research|February 22, 2012
miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cellsValentina Kovaleva, Rodrigo Mora, Yoon Jung Park, et al.Hemasphere|February 26, 2026
Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemiaRaúl Córdoba, Stephan Stilgenbauer, Paolo Ghia, et al.Pageof 40